Leadership
Management
Ronald J. Zenk, MBA
President and CEO
Mr. Zenk is the the President, CEO, member of the Board of Directors and Founder of Humanetics Corporation.
Rear Admiral Colin Chinn, MD, MHS, FACP
Chief Medical Officer
Dr. Chinn serves as Chief Medical Officer for Humanetics.
Michael D. Kaytor, Ph.D.
Vice President of Research and Development
Dr. Kaytor joined Humanetics in 2012 and serves as the Vice President of Research and Development.
Scott R. Thatcher
Director of Chemistry, Manufacturing and Controls
Mr. Thatcher joined Humanetics in 2023 as Director of CMC.
Board of Directors
Admiral Matthew L. Nathan, M.D.
Director
Admiral Nathan has served as a member of the Board since 2020 and as Chairman since 2022.
Medical and Programmatic Advisors
Karen L. Smith, MD, Ph.D.
Biotech/Pharmaceutical Executive, Board Director and Clinical/Scientific Advisor in the US, Europe, Canada and Australia
Dr. Smith is an accomplished executive with expertise in clinical design
Robert C. Miller, MD
Professor of Radiation Oncology, University of Maryland School of Medicine
Dr. Miller is a practicing radiation oncologist within the University of Maryland School of Medicine and is the Medical Director of the Maryland Proton Treatment Center.
Douglas W. Bryce
Advisor - CBRN Medical Countermeasure Contracting.
Mr. Bryce served as the Joint Program Executive Officer, Chemical, Biological, Radiological and Nuclear Defense.
Scientific Advisors
Isabel L. Jackson, Ph.D.
Assistant Professor of Radiation Oncology, University of Maryland
Dr. Jackson's area of expertise is focused on understanding the mechanisms underlying radiation effects in tissue.
Michael R. Landauer, Ph.D.
Scientist Emeritus, Armed Forces Radiobiology Research Institute
Dr. Landauer is a radiation countermeasure consultant.
Ronald G. Manning, Ph.D.
Former Chief, Chemical, Radiological and Nuclear Medical Countermeasures, BARDA
Dr. Manning is a distinguished scientists that has expertise in development of Medical Countermeasures.